Genito-Urinary System-Preparations Acting on the Prostate
= Additional active ingredients
Doxazosin (as mesylate).
PRESENTATION AND DOSSAGE
CAPLETS: 30 x 1 mg.
CAPLETS: 30 x 2 mg.
CAPLETS: 30 x 4 mg.
Treatment of benign prostatic hypertrophy.
Hypersensitivity to quinazolines, or any of the ingredients. Lactation. Adolescents under 16 years of age, hypotension (from benign prostatic hyperplasia indication only), benign prostatic hyperplasia and concomitant congestion of the upper urinary tract, chronic urinary tract infection or bladder stones, history of orthostatic hypotension, monotherapy in patients with either overflow bladder or anuria with or without progressive renal insufficiency.
The safety and efficacy in children have not been established. Patients with evidence of impaired liver function. Patient should be advised how to avoid symptoms resulting from postural hypotension and what measures to take should they develop. Impaired hepatic function. The ability to drive or use machinery may be impaired, especially when initiating therapy.
Pregnancy: Should be used only when the potential benefit outweighs the potential risk.
Vertigo, nausea, dizziness, headache, postural dizziness, somnolence, syncope.
MANUFACTURER & DISTRIBUTER:
Manufacturer: Dexcel Ltd.